HER2/neu Expression in Colorectal Cancers

Journal Title: International Journal of Contemporary Medical Research - Year 2017, Vol 4, Issue 6

Abstract

Introduction: Colorectal carcinoma ranks third among the most common leading causes of cancer-related mortality in the world. Her2/neu oncogene one is of four epidermal growth factor receptors. Clinically, amplification and/or overexpression of Her2/neu has been associated with poor prognosis in a number of tumor types such as breast and ovarian cancer. Conflicting data exist about the prevalence of HER-2/neu overexpression in colorectal cancer ranging from 0 to 83%. This study was done to check the expression of Her-2/neu in colorectal cancers. Material and Methods: The study included 50 patients with a histological diagnosis of colorectal cancers at our department between 2014 January and June 2015. HER2/neu immunohistochemistry was done on this cases and scored similar to invasive breast carcinomas.IHCs were analysed with grades and stages of colon cancers. Results:The mean age in this study was 60.04 years. Male female ratio was 1:1. Sixty percentage tumours were from colon and all the cases were adenocarcinoma NOS. Eighty percentage of cases were grade 1 tumours and stage B was the common stage noticed. Thirtytwo percentage of cases showed lymph node metastasis. Only 24% of cases showed Her2/neu positivity and maximum positive cases were from grade1 tumours. Maximum number of Her2/neu positivity was given by stage B tumours. Conclusion: HER2/neu protein expression was observed in colorectal cancer but rarely in the therapeutic range (2+ and 3+).

Authors and Affiliations

Suma S, Shameem K Ummerali

Keywords

Related Articles

Post Laparotomy Abdominal Wound Dehisence – A Study in Tertiary Care Hospital

Introduction: Wound dehiscence is defined as separation of all layers of incision. It may be partial or complete. Partial when one or more layers have separated but either the skin or the peritoneum is intact. Complete w...

Survival in Advanced Esophageal Cancer – Experience from a Tertiary Cancer Center

Introduction: Esophageal cancer is the eighth most common malignancy worldwide. In the Western world, esophageal adenocarcinoma has surpassed the incidence of squamous cell carcinoma (SCC). However in developing countrie...

A Comparitive Study of 2% Lidocaine Plus 0.5% Ropivacaine Versus 2% Lidocaine Plus 0.5% Bupivacaine for Peribulbar Anesthesia in Cataract Surgeries

Introduction: The goals of safe and effective anesthesia for intraocular surgery are to obtain good analgesia and akinesia without complications. Study aimed to determine efficacy and adverse cardiac effects of 2%lidocai...

A Retrospective Study of Wilms Tumour in Our Institute

Introduction: Wilms tumor (WT) accounting for 6-7% of all childhood cancers is the most common renal tumour in childhood. We conducted this study to review the outcome of multimodality treatment of Wilms’ tumor at our in...

Assessment of Diabetic Retinopathy by Fluorescein Angiography

Introduction: Diabetic retinopathy is one of the leading causes of blindness. According to “Statistics on blindness in the Model Reporting Area 1969-70, diabetic retinopathy was responsible for 11.1% of new cases of lega...

Download PDF file
  • EP ID EP427188
  • DOI -
  • Views 98
  • Downloads 0

How To Cite

Suma S, Shameem K Ummerali (2017). HER2/neu Expression in Colorectal Cancers. International Journal of Contemporary Medical Research, 4(6), 1240-1243. https://europub.co.uk/articles/-A-427188